TAK Currently At Short Entry Short

Takeda Pharmaceutical Company LimitedNYSE

Description

⋅ Dec 20, 2022 9:54 AM

TAK showing large wick rejection on weekly. Reward/risk here is 3.0 with trade as pictured and entries scattered across the red zone.